Skip to main content
. 2022 Dec 28;15(1):192. doi: 10.3390/cancers15010192

Figure 2.

Figure 2

Microbial community diversity across our study groups using the Chao1 approach for α-diversity and NMDS metric for β-diversity: (A) α-diversity of saliva samples from CRC patients and healthy controls; (B) α-diversity of stool samples from CRC patients and healthy controls; (C) α-diversity of saliva and stool samples from CRC patients; (D) α-diversity using CHAO1 of saliva and stool samples from healthy controls; (E) β-diversity of saliva samples from CRC patients and healthy controls; (F) β-diversity of stool samples from CRC patients and healthy controls; (G) β-diversity of saliva and stool samples from CRC patients; (H) β-diversity of saliva and stool samples from healthy controls.